Using Virtual Therapy for Lymphedema and Disability Post-Mastectomy: Meta-Analysis with Systematic Review.

IF 2.1 4区医学 Q2 OBSTETRICS & GYNECOLOGY

Breast Care Pub Date : 2025-06-11 DOI:10.1159/000546605

Islam Bani Mohammad, Muayyad Ahmad

{"title":"Using Virtual Therapy for Lymphedema and Disability Post-Mastectomy: Meta-Analysis with Systematic Review.","authors":"Islam Bani Mohammad, Muayyad Ahmad","doi":"10.1159/000546605","DOIUrl":null,"url":null,"abstract":"Introduction: This review and meta-analysis aimed to examine the effects of virtual reality (VR) therapy on lymphedema and disability management in post-mastectomy breast cancer patients, following PRISMA protocol.Methods: Databases were extensively searched, including Wiley Online Library, ProQuest, MEDLINE, CINAHL, Google Scholar, Science Direct, and SAGE Journals, covering studies from January 2016 to August 2024. This review was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.Results: Nine studies met the inclusion criteria. The findings indicate VR therapy effectively reduces post-mastectomy lymphedema and aids upper limb disability rehabilitation, with sessions lasting 10-50 min. The meta-analysis statistics showed a significant decrease in disability, measured by the disability of the arm, shoulder, and hand (DASH) scale, with an effect size of -0.931 (Z score = -2.713, p = 0.007) and a 95% confidence interval of -1.604 to -0.259.Conclusions: These results strongly support VR's efficacy in managing lymphedema and disability, recommending its integration into routine care at oncology centers and hospitals. This article explains compelling evidence that VR is effective in helping patients with lymphedema manage their disabilities. Rehabilitation programs using VR after mastectomy should be incorporated into the daily care in oncology centers and hospitals. Further interventional studies are needed to strengthen evidence and refine VRs clinical application.","PeriodicalId":9310,"journal":{"name":"Breast Care","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12240588/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000546605","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: This review and meta-analysis aimed to examine the effects of virtual reality (VR) therapy on lymphedema and disability management in post-mastectomy breast cancer patients, following PRISMA protocol.

Methods: Databases were extensively searched, including Wiley Online Library, ProQuest, MEDLINE, CINAHL, Google Scholar, Science Direct, and SAGE Journals, covering studies from January 2016 to August 2024. This review was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.

Results: Nine studies met the inclusion criteria. The findings indicate VR therapy effectively reduces post-mastectomy lymphedema and aids upper limb disability rehabilitation, with sessions lasting 10-50 min. The meta-analysis statistics showed a significant decrease in disability, measured by the disability of the arm, shoulder, and hand (DASH) scale, with an effect size of -0.931 (Z score = -2.713, p = 0.007) and a 95% confidence interval of -1.604 to -0.259.

Conclusions: These results strongly support VR's efficacy in managing lymphedema and disability, recommending its integration into routine care at oncology centers and hospitals. This article explains compelling evidence that VR is effective in helping patients with lymphedema manage their disabilities. Rehabilitation programs using VR after mastectomy should be incorporated into the daily care in oncology centers and hospitals. Further interventional studies are needed to strengthen evidence and refine VRs clinical application.

查看原文本刊更多论文

使用虚拟疗法治疗乳房切除术后淋巴水肿和残疾：荟萃分析与系统评价。

本综述和荟萃分析旨在研究虚拟现实（VR）治疗对乳房切除术后乳腺癌患者淋巴水肿和残疾管理的影响，遵循PRISMA协议。方法：广泛检索数据库，包括Wiley Online Library、ProQuest、MEDLINE、CINAHL、谷歌Scholar、Science Direct和SAGE Journals，涵盖2016年1月至2024年8月的研究。本综述按照系统评价和荟萃分析（PRISMA）指南的首选报告项目进行报道。结果：9项研究符合纳入标准。研究结果表明，VR治疗可有效减少乳房切除术后淋巴水肿，并有助于上肢残疾康复，疗程持续10-50分钟。meta分析统计数据显示，通过手臂、肩膀和手的残疾（DASH）量表测量，残疾显著降低，效应量为-0.931 (Z评分= -2.713,p = 0.007)， 95%置信区间为-1.604至-0.259。结论：这些结果有力地支持VR在治疗淋巴水肿和残疾方面的疗效，建议将其纳入肿瘤中心和医院的常规护理。这篇文章解释了令人信服的证据，VR是有效的帮助淋巴水肿患者管理他们的残疾。肿瘤中心和医院应将乳房切除术后的VR康复纳入日常护理。需要进一步的介入研究来加强证据和完善vr的临床应用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Breast Care 医学-妇产科学

CiteScore

4.40

自引率

4.80%

发文量

审稿时长

6-12 weeks

期刊介绍： ''Breast Care'' is a peer-reviewed scientific journal that covers all aspects of breast biology. Due to its interdisciplinary perspective, it encompasses articles on basic research, prevention, diagnosis, and treatment of malignant diseases of the breast. In addition to presenting current developments in clinical research, the scope of clinical practice is broadened by including articles on relevant legal, financial and economic issues.